Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
44°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LLY
Recent news which mentions LLY
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
October 02, 2024
Tickers
LLY
NVO
Tags
Biotech
Technicals
Benzinga
From
Benzinga
Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
October 02, 2024
Tickers
LLY
NEWS
NVO
Tags
Briefs
General
Market News
From
Benzinga
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
October 02, 2024
Tickers
LLY
NEWS
NVO
Tags
Top Stories
Media
News
From
Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Tickers
AZN
LLY
NEWS
NVO
Tags
Briefs
General
Market News
From
Benzinga
Eli Lilly's Options: A Look at What the Big Money is Thinking
October 01, 2024
Tickers
LLY
Tags
Options
BZI/UOA
Benzinga
From
Benzinga
Eli Lilly Eyes New Trials For Weight-Loss Drugs In Non-Obese Patients
October 01, 2024
Tickers
LLY
NEWS
SLH
Tags
Large Cap
Market News
General
From
Benzinga
Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight
October 01, 2024
Tickers
LLY
NEWS
Tags
General
weightloss
Zepbound
From
Benzinga
Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points
September 30, 2024
Tickers
LLY
Tags
General
Market News
Markets
From
Benzinga
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
Tickers
AQST
INCY
LLY
NEWS
Tags
News
LLY
Expert Ideas
From
Benzinga
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
September 30, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Biotech
RHHBY
NVO
From
Benzinga
This Is the Best Pharma Stock to Invest $1,000 in Right Now
September 29, 2024
Tickers
LLY
Tags
Recent Press Releases
Market News
LLY
From
Motley Fool
Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
September 28, 2024
Tickers
LLY
NVO
Tags
Recent Press Releases
NVO
Market News
From
Motley Fool
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
September 28, 2024
Tickers
BIIB
LLY
Tags
LLY
BIIB
Market News
From
Motley Fool
Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever
September 28, 2024
Tickers
LLY
LULU
Tags
LULU
Recent Press Releases
Market News
From
Motley Fool
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
September 27, 2024
Tickers
LLY
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.
September 26, 2024
Tickers
LLY
NVO
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
September 25, 2024
Tickers
LLY
Tags
KeyProj
weight loss drugs
Market News
From
Benzinga
Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users
September 25, 2024
Tickers
LLY
NEWS
NVO
Tags
Biotech
NVO
Stories That Matter
From
Benzinga
Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes
September 25, 2024
Tickers
LLY
NEWS
NVO
Tags
Top Stories
News
LLY
From
Benzinga
Eli Lilly Unusual Options Activity
September 25, 2024
Tickers
LLY
Tags
Benzinga
Markets
Market News
From
Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
Tickers
AMGN
LLY
NEWS
SNY
Tags
AMGN
Reiteration
Health Care
From
Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Tickers
LLY
MRK
NEWS
Tags
Top Stories
News
LLY
From
Benzinga
Why This Stock Could Be the Nvidia of Healthcare
September 25, 2024
Tickers
LLY
Tags
Recent Press Releases
Market News
LLY
From
Motley Fool
$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
September 24, 2024
Tickers
LLY
NEWS
Tags
BZI/POD
Market News
Benzinga
From
Benzinga
Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
September 24, 2024
Tickers
LLY
NEWS
Tags
Benzinga
Stories That Matter
Health Care
From
Benzinga
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
September 23, 2024
Tickers
LLY
Tags
LLY
Options
BZI/UOA
From
Benzinga
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
September 22, 2024
Tickers
LLY
Tags
Recent Press Releases
Market News
LLY
From
Motley Fool
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
September 21, 2024
Tickers
LLY
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
September 20, 2024
Tickers
LLY
NVO
VKTX
Tags
LLY
VKTX
NVO
From
Motley Fool
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
Tickers
CI
CVS
LLY
NEWS
Tags
Large Cap
Market News
CI
From
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.